Download PDF
J Neurol Surg A Cent Eur Neurosurg 2018; 79(02): 101-107
DOI: 10.1055/s-0037-1601874
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Brain Metastases of Non–Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection

Aida Ramos Antuña
1   Department of Neurosurgery, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
,
Marco Alvarez Vega
1   Department of Neurosurgery, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
,
Carmen Rodriguez Sanchez
2   Morphology and Cell Biology, Medical School, University of Oviedo, Oviedo, Asturias, Spain
,
Vanesa Martin Fernandez
2   Morphology and Cell Biology, Medical School, University of Oviedo, Oviedo, Asturias, Spain
› Author Affiliations
Further Information

Publication History

15 August 2016

16 February 2017

Publication Date:
06 June 2017 (online)

    Permissions and Reprints

Abstract

Background and Study Aims Bronchogenic carcinoma is the cancer that most commonly metastasizes to the brain. The standard treatment schedule for these patients is still unclear, although recommendation level 1 class I advocates for surgical resection together with postoperative whole-brain radiotherapy for patients with good Karnofsky performance status (KPS). We performed a study to identify prognostic factors for the long-term survival of patients with brain metastases from non–small cell lung cancer (NSCLC).

Patients This retrospective single-center study included 71 patients with brain metastases from NSCLC having undergone surgical metastasectomy between January 2002 and January 2015.

Results The average age was 58.8 years. A total of 85.9% of the lesions were located in the supratentorial region, 61.9% of the lesions were < 3 cm, and 80.3% of cases were solitary brain metastases. Complete resection was achieved in 90.1% of patients. Clinical debut with motor involvement was associated with higher rates of incomplete surgical resection. Patients with motor deficits had a worse preoperative KPS. The preoperative KPS was > 70 in 74.6% of patients, and the postoperative KPS was > 70 in 85.9% of patients. Overall, 84.5% of the brain surgeries had no complications. Brain metastases were diagnosed as a synchronous presentation in 64.7% of patients.

The average survival after brain surgery was 20.38 months. The survival rate was 66.2% at 6 months, 45.1% at 12 months, 22.5% at 24 months, 14.1% at 36 months, and 8.5% at 48 months. Patients < 55 years of age showed a higher survival rate at 12 months and 48 months. Patients > 70 years of age showed a higher mortality rate at 6 months. Complete surgical brain metastasis resection was associated with an increased survival at 6 months, and patients undergoing primary lung surgery had better survival rates at 48 months. A preoperative KPS > 70% improved the prognosis of patients at 6 and 24 months. Surgical complications reduced survival at 6 and 12 months.

Conclusion Surgical resection may be beneficial for a given group of patients: a preoperative KPS > 70; age < 55 years, complete surgical brain metastasis resection, no surgical complications, patients with primary lung surgery, and complete radiotherapy treatment. We did not find any significant difference regarding further factors that probably affect survival rates such as size or number of metastases.

Keywords

non–small cell lung cancer - brain metastases - prognostic factors - surgical resection
 

  • References

  • 1 Barlesi F, Khobta N, Tallet A. , et al. Management of brain metastases for lung cancer patients [in French]. Bull Cancer 2013; 100 (03) 303-308
    PubMedGoogle Scholar
  • 2 Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer 2007; 109 (08) 1668-1675
    CrossrefPubMedGoogle Scholar
  • 3 Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005; 75 (01) 5-14
    CrossrefPubMedGoogle Scholar
  • 4 Fuentes R, Bonfill X, Exposito J. Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. Cochrane Database Syst Rev 2006; (01) CD004840
    PubMedGoogle Scholar
  • 5 Nieder C, Spanne O, Mehta MP, Grosu AL, Geinitz H. Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?. Cancer 2011; 117 (11) 2505-2512
    CrossrefPubMedGoogle Scholar
  • 6 Nieder C, Grosu AL, Gaspar LE. Stereotactic radiosurgery (SRS) for brain metastases: a systematic review. Radiat Oncol 2014; 9: 155
    CrossrefPubMedGoogle Scholar
  • 7 Owonikoko TK, Arbiser J, Zelnak A. , et al. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol 2014; 11 (04) 203-222
    CrossrefPubMedGoogle Scholar
  • 8 Lo CK, Yu CH, Ma CC, Ko KM, Leung SC. Surgical management of primary non-small-cell carcinoma of lung with synchronous solitary brain metastasis: local experience. Hong Kong Med J 2010; 16 (03) 186-191
    PubMedGoogle Scholar
  • 9 Granone P, Margaritora S, D'Andrilli A, Cesario A, Kawamukai K, Meacci E. Non-small cell lung cancer with single brain metastasis: the role of surgical treatment. Eur J Cardiothorac Surg 2001; 20 (02) 361-366
    CrossrefPubMedGoogle Scholar
  • 10 Connolly EP, Mathew M, Tam M. , et al. Involved field radiation therapy after surgical resection of solitary brain metastases—mature results. Neuro Oncol 2013; 15 (05) 589-594
    CrossrefPubMedGoogle Scholar
  • 11 Porta R, Sánchez-Torres JM, Paz-Ares L. , et al. Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation. Eur Respir J 2011; 37 (03) 624-631
    CrossrefPubMedGoogle Scholar
  • 12 Qin H, Wang C, Jiang Y, Zhang X, Zhang Y, Ruan Z. Patients with single brain metastasis from non-small cell lung cancer equally benefit from stereotactic radiosurgery and surgery: a systematic review. Med Sci Monit 2015; 21: 144-152
    CrossrefPubMedGoogle Scholar
  • 13 Kalkanis SN, Kondziolka D, Gaspar LE. , et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96 (01) 33-43
    CrossrefPubMedGoogle Scholar
  • 14 Flannery TW, Suntharalingam M, Regine WF. , et al. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery. Int J Radiat Oncol Biol Phys 2008; 72 (01) 19-23
    CrossrefPubMedGoogle Scholar
  • 15 Gaspar L, Scott C, Rotman M. , et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37 (04) 745-751
    CrossrefPubMedGoogle Scholar
  • 16 Sperduto PW, Kased N, Roberge D. , et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012; 30 (04) 419-425
    PubMedGoogle Scholar
  • 17 Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008; 70 (02) 510-514
    CrossrefPubMedGoogle Scholar
  • 18 Andrews DW, Scott CB, Sperduto PW. , et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363 (9422): 1665-1672
    CrossrefPubMedGoogle Scholar
  • 19 O'Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O'Fallon JR. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003; 55 (05) 1169-1176
    CrossrefPubMedGoogle Scholar
  • 20 Koutras AK, Marangos M, Kourelis T. , et al. Surgical management of cerebral metastases from non-small cell lung cancer. Tumori 2003; 89 (03) 292-297
    CrossrefPubMedGoogle Scholar
  • 21 World Health Organization (WHO). Global Status Report on Alcohol and Health 2014. Geneva, Switzerland: WHO; 2014
    Google Scholar
  • 22 Bonnette P, Puyo P, Gabriel C. , et al; Groupe Thorax. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001; 119 (05) 1469-1475
    CrossrefPubMedGoogle Scholar
  • 23 Iwasaki A, Shirakusa T, Yoshinaga Y, Enatsu S, Yamamoto M. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. Eur J Cardiothorac Surg 2004; 26 (03) 488-493
    CrossrefPubMedGoogle Scholar
  • 24 Penel N, Brichet A, Prevost B. , et al. Pronostic factors of synchronous brain metastases from lung cancer. Lung Cancer 2001; 33 (2-3): 143-154
    CrossrefPubMedGoogle Scholar
  • 25 Abrahams JM, Torchia M, Putt M, Kaiser LR, Judy KD. Risk factors affecting survival after brain metastases from non-small cell lung carcinoma: a follow-up study of 70 patients. J Neurosurg 2001; 95 (04) 595-600
    CrossrefPubMedGoogle Scholar
  • 26 Saitoh Y, Fujisawa T, Shiba M. , et al. Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer. Lung Cancer 1999; 24 (02) 99-106
    CrossrefPubMedGoogle Scholar
  • 27 Khalsa SS, Chinn M, Krucoff M, Sherman JH. The role of stereotactic radiosurgery for multiple brain metastases in stable systemic disease: a review of the literature. Acta Neurochir (Wien) 2013; 155 (07) 1321-1327 ; discussion 1327–1328
    CrossrefPubMedGoogle Scholar
  • 28 Bindal AK, Bindal RK, Hess KR. , et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 1996; 84 (05) 748-754
    CrossrefPubMedGoogle Scholar
  • 29 Kanou T, Okami J, Tokunaga T. , et al. Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis. Surg Today 2014; 44 (07) 1321-1327
    CrossrefPubMedGoogle Scholar
  • 30 Kanou T, Okami J, Tokunaga T, Ishida D, Kuno H, Higashiyama M. Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer. Thorac Cancer 2015; 6 (01) 38-42
    CrossrefPubMedGoogle Scholar
  • 31 Chaichana KL, Acharya S, Flores M. , et al. Identifying better surgical candidates among recursive partitioning analysis class 2 patients who underwent surgery for intracranial metastases. World Neurosurg 2014; 82 (1–2): e267-e275
    CrossrefPubMedGoogle Scholar
  • 32 Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS. ; American College of Physicians. Lung cancer. Special treatment issues. Chest 2003; 123 (1, Suppl) 244S-258S
    CrossrefPubMedGoogle Scholar
  • 33 Pollock BE, Brown PD, Foote RL, Stafford SL, Schomberg PJ. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol 2003; 61 (01) 73-80
    CrossrefPubMedGoogle Scholar
  • 34 Hong N, Yoo H, Gwak HS, Shin SH, Lee SH. Outcome of surgical resection of symptomatic cerebral lesions in non-small cell lung cancer patients with multiple brain metastases. Brain Tumor Res Treat 2013; 1 (02) 64-70
    CrossrefPubMedGoogle Scholar
  • 35 Aoyama H, Shirato H, Tago M. , et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295 (21) 2483-2491
    CrossrefPubMedGoogle Scholar
  • 36 Soffietti R, Ducati A, Rudà R. Brain metastases. Handb Clin Neurol 2012; 105: 747-755
    PubMedGoogle Scholar
  • 37 Muacevic A, Kreth FW, Horstmann GA. , et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 1999; 91 (01) 35-43
    CrossrefPubMedGoogle Scholar
  • 38 Xu Q, Wang Y, Liu H. , et al. Treatment outcome for patients with primary NSCLC and synchronous solitary metastasis. Clin Transl Oncol 2013; 15 (10) 802-809
    CrossrefPubMedGoogle Scholar
  • 39 Melloni G, Bandiera A, Gregorc V. , et al. Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience. J Cardiovasc Surg (Torino) 2011; 52 (04) 613-619
    PubMedGoogle Scholar
  • 40 Sánchez de Cos J, Sojo González MA, Montero MV, Pérez Calvo MC, Vicente MJ, Valle MH. Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors. Lung Cancer 2009; 63 (01) 140-145
    CrossrefPubMedGoogle Scholar
  • 41 Gray PJ, Mak RH, Yeap BY. , et al. Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival. Lung Cancer 2014; 85 (02) 239-244
    CrossrefPubMedGoogle Scholar
  • 42 Endo C, Hasumi T, Matsumura Y. , et al. A prospective study of surgical procedures for patients with oligometastatic non-small cell lung cancer. Ann Thorac Surg 2014; 98 (01) 258-264
    CrossrefPubMedGoogle Scholar
  • 43 Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5 Suppl): e369-399s
    CrossrefPubMedGoogle Scholar
  • 44 Mintz A, Perry J, Spithoff K, Chambers A, Laperriere N. Management of single brain metastasis: a practice guideline. Curr Oncol 2007; 14 (04) 131-143
    CrossrefPubMedGoogle Scholar
  • 45 Arita H, Narita Y, Miyakita Y, Ohno M, Sumi M, Shibui S. Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery. J Neurooncol 2014; 116 (01) 145-152
    CrossrefPubMedGoogle Scholar
  • 46 Kocher M, Wittig A, Piroth MD. , et al. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 2014; 190 (06) 521-532
    CrossrefPubMedGoogle Scholar
  • 47 Patil C, Pricola K, Sarmiento J, Garg S, Bryant A, Black K. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev 2012; (09) CD006121
    PubMedGoogle Scholar
  • 48 Hisao SH, Lin HC, Chou YT. , et al. Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients. Lung Cancer 2013; 81 (03) 445-461
    CrossrefPubMedGoogle Scholar
  • 49 Burel-Vandenbos F, Ambrosetti D, Coutts M, Pedeutour F. EGFR mutation status in brain metastases of non-small cell lung carcinoma. J Neurooncol 2013; 111 (01) 1-10
    CrossrefPubMedGoogle Scholar